BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23733270)

  • 1. Desloratadine-montelukast combination improves quality of life and decreases nasal obstruction in patients with perennial allergic rhinitis.
    Cingi C; Oghan F; Eskiizmir G; Yaz A; Ural A; Erdogmus N
    Int Forum Allergy Rhinol; 2013 Oct; 3(10):801-6. PubMed ID: 23733270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis.
    Holmberg K; Tonnel AB; Dreyfus I; Olsson P; Cougnard J; Mesbah K; Devillier P
    Allergy; 2009 Nov; 64(11):1663-70. PubMed ID: 19740126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
    Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
    Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
    J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
    Patel P; Philip G; Yang W; Call R; Horak F; LaForce C; Gilles L; Garrett GC; Dass SB; Knorr BA; Reiss TF
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of montelukast on quality of life in patients with persistent allergic rhinitis.
    Cingi C; Ozlugedik S
    Otolaryngol Head Neck Surg; 2010 May; 142(5):654-8. PubMed ID: 20416451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
    Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P
    Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of Montelukast plus Budesonide nasal spray and Desloratadine citrate disodium in treating moderate and severe persistent allergic rhinitis].
    Wang R; Zhang C
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 29(23):2041-3. PubMed ID: 27101674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis].
    Lu Y; Yin M; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Aug; 49(8):659-67. PubMed ID: 25351124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion.
    Anolik R
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):683-94. PubMed ID: 19473112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion.
    McLeod RL; Mingo GG; Xu X; Palamanda J; Hunter JC; Jia Y
    Am J Rhinol Allergy; 2009; 23(6):e17-22. PubMed ID: 19769798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine.
    Ciebiada M; Barylski M; Gorska Ciebiada M
    Am J Rhinol Allergy; 2013; 27(2):e58-62. PubMed ID: 23562192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of montelukast for treating perennial allergic rhinitis.
    Philip G; Williams-Herman D; Patel P; Weinstein SF; Alon A; Gilles L; Tozzi CA; Dass SB; Reiss TF
    Allergy Asthma Proc; 2007; 28(3):296-304. PubMed ID: 17619558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in patients with persistent allergic rhinitis treated with desloratadine monotherapy or desloratadine plus montelucast combination.
    Erdoğan BA; Sanlı A; Paksoy M; Altın G; Aydın S
    Kulak Burun Bogaz Ihtis Derg; 2014; 24(4):217-24. PubMed ID: 25046070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
    Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.